Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 5;26(9):2709.
doi: 10.3390/molecules26092709.

The Anti-Leukemic Activity of Natural Compounds

Affiliations
Review

The Anti-Leukemic Activity of Natural Compounds

Coralia Cotoraci et al. Molecules. .

Abstract

The use of biologically active compounds has become a realistic option for the treatment of malignant tumors due to their cost-effectiveness and safety. In this review, we aimed to highlight the main natural biocompounds that target leukemic cells, assessed by in vitro and in vivo experiments or clinical studies, in order to explore their therapeutic potential in the treatment of leukemia: acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute lymphocytic leukemia (ALL), and chronic lymphocytic leukemia (CLL). It provides a basis for researchers and hematologists in improving basic and clinical research on the development of new alternative therapies in the fight against leukemia, a harmful hematological cancer and the leading cause of death among patients.

Keywords: anti-leukemic; antioxidants; flavonoids; lymphoblastic leukemia; myeloid leukemia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Natural compounds against acute myeloid leukemia (AML).
Figure 2
Figure 2
Natural compounds against chronic myeloid leukemia (CML).
Figure 3
Figure 3
Natural compounds against acute lymphoblastic leukemia (ALL).
Figure 4
Figure 4
Natural compounds against chronic lymphocytic leukemia (CLL).

References

    1. Talib W.H., Alsalahat I., Daoud S., Abutayeh R.F., Mahmod A.I. Plant-derived natural products in cancer research: Extraction, mechanism of action, and drug formulation. Molecules. 2020;25:5319. doi: 10.3390/molecules25225319. - DOI - PMC - PubMed
    1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Watts J., Nimer S. Recent advances in the understanding and treatment of acute myeloid leukemia. F1000Research. 2018;7:1196. doi: 10.12688/f1000research.14116.1. - DOI - PMC - PubMed
    1. Rafiq S., Raza M.H., Younas M., Naeem F., Adeeb R., Iqbal J., Anwar P., Sajid U., Manzoor H.M. Molecular targets of curcumin and future therapeutic role in leukemia. JBM. 2018;6:33–50. doi: 10.4236/jbm.2018.64003. - DOI
    1. Naimi A., Entezari A., Hagh M.F., Hassanzadeh A., Saraei R., Solali S. Quercetin sensitizes human myeloid leukemia KG-1 cells against TRAIL-induced apoptosis. J. Cell Physiol. 2019;234:13233–13241. doi: 10.1002/jcp.27995. - DOI - PubMed